Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon accumulation in cirrhotic rat liver

I Miyajima1, M Sata, K Gondo

  • 1Second Department of Medicine, Kurume University, School of Medicine, Fukuoka, Japan.

Journal of Viral Hepatitis
|January 1, 1996
PubMed
Summary

Cirrhosis hinders interferon (IFN) binding to liver cells, reducing its accumulation. This impaired uptake of therapeutic interferon may explain poor treatment responses in patients with liver cirrhosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Purification and characterization of DNA topoisomerase IV in Escherichia coli.

The Journal of biological chemistry·1992
Same author

Identification of inducible calmodulin-dependent nitric oxide synthase in the liver of rats.

The Journal of biological chemistry·1992
Same author

Inhibition of cell attachment, invasion and metastasis of human carcinoma cells by anti-integrin beta 1 subunit antibody.

Japanese journal of cancer research : Gann·1992
Same author

Enzymatic inactivation of tachykinin neurotransmitters in the isolated spinal cord of the newborn rat.

Neuroscience research·1992
Same author

Alpha-fetoprotein-producing immature mediastinal teratoma showing rapid and massive recurrent growth in an adult.

Acta pathologica japonica·1992
Same author

Ki-67 antibody labeling index in colorectal carcinoma.

Journal of clinical gastroenterology·1992

Area of Science:

  • Hepatology
  • Virology
  • Pharmacology

Background:

  • Therapeutic efficacy of interferon (IFN) in chronic hepatitis C is affected by liver disease progression.
  • Previous studies indicated reduced 2',5'-oligoadenylate synthetase activity in cirrhotic rat livers post-IFN injection.
  • The mechanism behind reduced IFN efficacy in cirrhosis requires further investigation.

Purpose of the Study:

  • To investigate the reason for decreased 2',5'-oligoadenylate synthetase activity in cirrhotic rat livers after IFN administration.
  • To determine the distribution and accumulation of interferon in cirrhotic rat livers.

Main Methods:

  • Induction of cirrhosis in rats using thioacetamide.
  • Administration of human lymphoblastoid interferon labeled with iodine-125 ([125I]LyIFN).

Related Experiment Videos

  • Quantitative analysis using microautoradiography to assess [125I]LyIFN accumulation and distribution.

    • Main Results:

    • Accumulation of [125I]LyIFN in cirrhotic rat livers was significantly reduced by approximately 50% compared to control rats.
    • Microautoradiography revealed minimal [125I]LyIFN binding to hepatocytes in cirrhotic livers.
    • A significant accumulation of [125I]LyIFN was observed on collagen fibers within the cirrhotic livers.

    Conclusions:

    • Cirrhosis impedes the binding of interferon to its receptors on hepatocytes.
    • Reduced interferon uptake by hepatocytes in cirrhotic livers may contribute to diminished therapeutic responses observed in patients with cirrhosis.
    • Targeting collagen fibers or improving hepatocyte receptor accessibility could be potential therapeutic strategies.